Nutrition, T-2 Toxin, and Gut Microbiota in Kashin–Beck Disease: Current Evidence and Proposed Links Within the Microbiota–Gut–Osteochondral Framework
- 1Department of Occupational and Environmental Health, School of Public Health, Health Science Center, Xi’an Jiaotong University, Xi’an 710061, China
- 2Collaborative Innovation Center of Endemic Disease and Health Promotion for Silk Road Region, School of Public Health, Health Science Center, Xi’an Jiaotong University, Xi’an 710061, China
- 3Key Laboratory of Trace Elements and Endemic Diseases, National Health and Family Planning Commission, School of Public Health, Health Science Center, Xi’an Jiaotong University, Xi’an 710061, China
Abstract
Kashin–Beck disease (KBD) is an endemic osteoarthropathy characterized by the degeneration and necrosis of articular cartilage and epiphyseal growth plate cartilage, with disease onset occurring predominantly during childhood. Its etiology has long been associated with environmental and nutritional factors, particularly selenium deficiency, T-2 toxin exposure, and dietary imbalance. Recent studies have also reported alterations in gut microbial composition and metabolic profiles in patients with KBD, raising the possibility that the gut microbiota may represent an additional component of its multifactorial etiology. This narrative review critically evaluates current evidence linking nutritional factors, T-2 toxin exposure, gut microbial alterations, and osteochondral injury in KBD, with particular attention to the level of evidence supporting these relationships. Direct human evidence is currently limited to a small number of predominantly cross-sectional microbiome and metabolomic studies, largely involving adults with established KBD. KBD-related experimental models provide evidence that selenium deficiency and T-2 toxin exposure can induce osteochondral injury, including combined-exposure effects, and experimental studies also indicate that these exposures can be associated with alterations in gut microbial composition. However, these findings do not demonstrate that gut microbial changes mediate exposure-related osteochondral injury. Proposed pathways involving short-chain fatty acids (SCFAs), intestinal-barrier dysfunction, lipopolysaccharide (LPS)-related inflammatory signaling, immune regulation, and bone remodeling are supported mainly by experimental or mechanistic evidence from non-KBD settings and have not been validated as an integrated causal pathway in KBD. The microbiota–gut–osteochondral framework should therefore be regarded as an evidence-stratified, hypothesis-generating model. Prospective studies in children and adolescents from endemic areas, together with factorial exposure models, direct measurement of proposed intermediate mediators, and functional microbiota-manipulation experiments, are needed to determine whether gut microbial alterations contribute causally to KBD development.
Related
- Autophagy as a Proposed Regulatory Interface in the Gut Microbiota-Cardiovascular Axis.
- Nutrition-Derived Bioactive Polyphenolic Metabolites Produced by Gut Microbiota and Their Potential Role in Bone Health
- Microbiome-Guided Maternal and Child Nutrition: A Structured Narrative Review of Indigenous African Foods, Fermented Foods, and Emerging Evidence.
- Microbiota–host crosstalk in ulcerative colitis: mechanistic evidence and translational prospects for traditional Chinese medicine
- The Gut Microbiota as a Mediator of the Metabolic Benefits of Fungi and Their Polysaccharides: A Review of Evidence Addressing Causality
BibTeX
@article{liu2026nutrition,
title = {{Nutrition, T-2 Toxin, and Gut Microbiota in Kashin–Beck Disease: Current Evidence and Proposed Links Within the Microbiota–Gut–Osteochondral Framework}},
author = {Yang Liu and Chaowei Wang and Liangyu Cui and Xiong Guo and Xi Wang and Yujie Ning},
journal = {Metabolites},
year = {2026},
month = oct,
doi = {10.3390/metabo16100787},
url = {https://www.mdpi.com/2218-1989/16/10/787},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Nutrition, T-2 Toxin, and Gut Microbiota in Kashin–Beck Disease: Current Evidence and Proposed Links Within the Microbiota–Gut–Osteochondral Framework
AU - Yang Liu
AU - Chaowei Wang
AU - Liangyu Cui
AU - Xiong Guo
AU - Xi Wang
AU - Yujie Ning
PY - 2026
DA - 2026/10/01
JO - Metabolites
DO - 10.3390/metabo16100787
UR - https://www.mdpi.com/2218-1989/16/10/787
AB - Kashin–Beck disease (KBD) is an endemic osteoarthropathy characterized by the degeneration and necrosis of articular cartilage and epiphyseal growth plate cartilage, with disease onset occurring predominantly during childhood. Its etiology has long been associated with environmental and nutritional factors, particularly selenium deficiency, T-2 toxin exposure, and dietary imbalance. Recent studies have also reported alterations in gut microbial composition and metabolic profiles in patients with KBD, raising the possibility that the gut microbiota may represent an additional component of its multifactorial etiology. This narrative review critically evaluates current evidence linking nutritional factors, T-2 toxin exposure, gut microbial alterations, and osteochondral injury in KBD, with particular attention to the level of evidence supporting these relationships. Direct human evidence is currently limited to a small number of predominantly cross-sectional microbiome and metabolomic studies, largely involving adults with established KBD. KBD-related experimental models provide evidence that selenium deficiency and T-2 toxin exposure can induce osteochondral injury, including combined-exposure effects, and experimental studies also indicate that these exposures can be associated with alterations in gut microbial composition. However, these findings do not demonstrate that gut microbial changes mediate exposure-related osteochondral injury. Proposed pathways involving short-chain fatty acids (SCFAs), intestinal-barrier dysfunction, lipopolysaccharide (LPS)-related inflammatory signaling, immune regulation, and bone remodeling are supported mainly by experimental or mechanistic evidence from non-KBD settings and have not been validated as an integrated causal pathway in KBD. The microbiota–gut–osteochondral framework should therefore be regarded as an evidence-stratified, hypothesis-generating model. Prospective studies in children and adolescents from endemic areas, together with factorial exposure models, direct measurement of proposed intermediate mediators, and functional microbiota-manipulation experiments, are needed to determine whether gut microbial alterations contribute causally to KBD development.
SN - 2218-1989
ER -